PURPOSE: Family history guides cancer prevention and genetic testing. We sought to estimate the population prevalence of increased familial risk for breast, ovarian, endometrial, prostate, and colorectal cancers and hereditary cancer syndromes that include these cancers. METHODS: Using the 2005 California Health Interview Survey data, a weak, moderate, or strong familial cancer risk was assigned to 33,187 respondents. Guidelines were applied to identify individuals with hereditary breast-ovarian cancer and hereditary nonpolyposis colon cancer. RESULTS: Among respondents without a personal history of cancer, familial breast cancer was most prevalent; 7% had a moderate and 5% a strong familial risk. Older individuals and women were more likely to report family history of cancer. Generally, whites had the highest prevalence, and Asians and Latinos had the lowest prevalence. Among women without a personal history of breast or ovarian cancer, 2.5% met criteria for hereditary breast-ovarian cancer, and among individuals without a personal history of colorectal, endometrial or ovarian cancer, 1.1% met criteria for hereditary nonpolyposis colon cancer. CONCLUSIONS: We provide population-based prevalence estimates for moderate and strong familial risk for five common cancers and hereditary breast-ovarian cancer and hereditary nonpolyposis colon cancer. Such estimates are helpful in planning and evaluation of genetic services and prevention programs, and assessment of cancer surveillance and prevention strategies.
PURPOSE: Family history guides cancer prevention and genetic testing. We sought to estimate the population prevalence of increased familial risk for breast, ovarian, endometrial, prostate, and colorectal cancers and hereditary cancer syndromes that include these cancers. METHODS: Using the 2005 California Health Interview Survey data, a weak, moderate, or strong familial cancer risk was assigned to 33,187 respondents. Guidelines were applied to identify individuals with hereditary breast-ovarian cancer and hereditary nonpolyposis colon cancer. RESULTS: Among respondents without a personal history of cancer, familial breast cancer was most prevalent; 7% had a moderate and 5% a strong familial risk. Older individuals and women were more likely to report family history of cancer. Generally, whites had the highest prevalence, and Asians and Latinos had the lowest prevalence. Among women without a personal history of breast or ovarian cancer, 2.5% met criteria for hereditary breast-ovarian cancer, and among individuals without a personal history of colorectal, endometrial or ovarian cancer, 1.1% met criteria for hereditary nonpolyposis colon cancer. CONCLUSIONS: We provide population-based prevalence estimates for moderate and strong familial risk for five common cancers and hereditary breast-ovarian cancer and hereditary nonpolyposis colon cancer. Such estimates are helpful in planning and evaluation of genetic services and prevention programs, and assessment of cancer surveillance and prevention strategies.
Authors: Argyrios Ziogas; Nora K Horick; Anita Y Kinney; Jan T Lowery; Susan M Domchek; Claudine Isaacs; Constance A Griffin; Patricia G Moorman; Karen L Edwards; Deirdre A Hill; Jonathan S Berg; Gail E Tomlinson; Hoda Anton-Culver; Louise C Strong; Carol H Kasten; Dianne M Finkelstein; Sharon E Plon Journal: JAMA Date: 2011-07-13 Impact factor: 56.272
Authors: Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt Journal: Am J Gastroenterol Date: 2015-02-03 Impact factor: 10.864
Authors: Margot M Koeneman; Arnold-Jan Kruse; Simone J S Sep; Cynthia S Gubbels; Brigitte F M Slangen; Toon van Gorp; Alberto Lopes; Encarna Gomez-Garcia; Roy F P M Kruitwagen Journal: Fam Cancer Date: 2014-09 Impact factor: 2.375
Authors: Esther M John; Alison J Canchola; Meera Sangaramoorthy; Jocelyn Koo; Alice S Whittemore; Dee W West Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254
Authors: Catharine Wang; Ananda Sen; Mack T Ruffin; Donald E Nease; Robert Gramling; Louise S Acheson; Suzanne M O'Neill; Wendy S Rubinstein Journal: Am J Prev Med Date: 2012-10 Impact factor: 5.043
Authors: June C Carroll; Denise Campbell-Scherer; Joanne A Permaul; Jesse Myers; Donna P Manca; Christopher Meaney; Rahim Moineddin; Eva Grunfeld Journal: Can Fam Physician Date: 2017-01 Impact factor: 3.275